RGVCX | RMAGX | RGVCX / RMAGX | |
Total Expense Ratio | 0.89 | 0.26 | 342% |
Annual Report Gross Expense Ratio | 0.93 | 0.31 | 300% |
Fund Existence | 23 years | 15 years | - |
Gain YTD | 6.909 | 8.042 | 86% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 23.9B | 12.2B | 196% |
Annual Yield % from dividends | 3.76 | 4.65 | 81% |
Returns for 1 year | 5.27 | 6.39 | 82% |
Returns for 3 years | 12.84 | 17.67 | 73% |
Returns for 5 years | -6.94 | -0.64 | 1,088% |
Returns for 10 years | 3.24 | 12.47 | 26% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XHYT | 34.89 | 0.15 | +0.45% |
BondBloxx US HY Telecm Md Tech Sctr ETF | |||
XIDV | 31.93 | 0.13 | +0.42% |
Franklin Intl Div Mltplr Idx ETF | |||
RYSE | 22.66 | N/A | N/A |
Cboe Vest 10 Yr Intst Rt Hdg ETF | |||
PPH | 91.85 | -0.04 | -0.04% |
VanEck Pharmaceutical ETF | |||
NBCM | 23.72 | -0.12 | -0.50% |
Neuberger Berman Commodity Stgy ETF |